Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse and / or Refractory Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05299424
What this trial is testing

CM336 in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Keymed Biosciences Co.Ltd 48
Early research (Phase 1)Study completedNCT03274219
What this trial is testing

Study of bb21217 in Multiple Myeloma

Who this might be right for
Multiple Myeloma
2seventy bio 72
Testing effectiveness (Phase 2)Study completedNCT01962792
What this trial is testing

Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pharmacyclics LLC. 84
Early research (Phase 1)Ended earlyNCT03502577
What this trial is testing

BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT01592370
What this trial is testing

An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma

Who this might be right for
Non-Hodgkin's LymphomaHodgkin LymphomaMultiple Myeloma
Bristol-Myers Squibb 320
Not applicableTemporarily pausedNCT03752541
What this trial is testing

Efficacy and Safety Evaluation of BCMA-UCART

Who this might be right for
Multiple Myeloma
Bioray Laboratories 20
Large-scale testing (Phase 3)Ended earlyNCT04649060
What this trial is testing

Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma

Who this might be right for
Relapsed Multiple MyelomaRelapsed-Refractory Multiple Myeloma
Oncopeptides AB 54
Large-scale testing (Phase 3)Looking for participantsNCT07772024
What this trial is testing

Inobrodib, Pomalidomide and Dexamethasone Versus Standard Available Therapy in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma RefractoryMultiple Myeloma in Relapse
CellCentric Ltd. 450
Large-scale testing (Phase 3)Active Not RecruitingNCT06208150
What this trial is testing

A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 838
Testing effectiveness (Phase 2)Study completedNCT02206425
What this trial is testing

Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Oncotherapeutics 45
Testing effectiveness (Phase 2)Study completedNCT00809276
What this trial is testing

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Who this might be right for
LymphomaMultiple MyelomaLeukemia+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 92
Testing effectiveness (Phase 2)Study completedNCT01168804
What this trial is testing

Bendamustine Plus Bortezomib Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Austrian Forum Against Cancer 79
Post-approval studies (Phase 4)Study completedNCT03934684
What this trial is testing

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed Refractory Multiple Myeloma
Amgen 101
Early research (Phase 1)Study completedNCT01372540
What this trial is testing

Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Who this might be right for
Plasma Cell LeukemiaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
M.D. Anderson Cancer Center 76
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Testing effectiveness (Phase 2)Study completedNCT00445484
What this trial is testing

Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Testing effectiveness (Phase 2)Study completedNCT02119468
What this trial is testing

Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell MyelomaRecurrent Plasma Cell Myeloma
City of Hope Medical Center 32
Testing effectiveness (Phase 2)Ended earlyNCT03683277
What this trial is testing

IPD in RRMM Characterized With Genomic Abnormalities of Adverse Prognostic

Who this might be right for
Multiple MyelomaRelapsed and Refractory Multiple MyelomaGenetic Condition
Intergroupe Francophone du Myelome 26
Large-scale testing (Phase 3)UnknownNCT00747877
What this trial is testing

High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Leeds Cancer Centre at St. James's University Hospital 460
Testing effectiveness (Phase 2)Study completedNCT00051311
What this trial is testing

Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers

Who this might be right for
Hematologic Neoplasms
National Cancer Institute (NCI) 62
Next Page